Astante Therapeutics

120 N Pine St Ste 270A
Spokane, WA 99202

Astante Therapeutics, based in Spokane, WA, is pioneering a novel treatment approach known as Bystander Assisted ImmunoTherapy (BAIT) to combat multidrug-resistant cancers. Their innovative drug delivery strategy leverages the unique mechanisms of drug resistance in cancer cells to enhance the efficacy of immunotherapeutic agents while minimizing harm to healthy cells.

The company is currently advancing two lead drug candidates, BAIT719 and BAIT628, which have shown promise in preclinical safety studies and are entering early efficacy trials for metastatic prostate and triple-negative breast cancers. If successful, these therapeutics could significantly improve survival rates for patients facing the challenges of multidrug resistance in cancer treatment.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesWashingtonSpokaneAstante Therapeutics

Partial Data by Infogroup (c) 2025. All rights reserved.